Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

P&G

This article was originally published in The Tan Sheet

Executive Summary

Firm will continue test-marketing Elations Dietary Supplement drink despite Sept. 26 announcement it is no longer pursuing joint venture with Coca-Cola to market health and wellness beverages, snacks. P&G debuted Elations - a beverage targeting "joint flexibility and skeletal strength" and containing glucosamine, calcium and vitamin C - in "learning" markets in Cape Coral and Sarasota, Fla. earlier this year. The 8-oz. drink comes in Cranberry Apple Twist and Ruby Red Grapefruit Lift flavors, retailing for about $10 for an eight-pack, $35 for a 28-pack. The Elations brand originally was to be housed under the P&G/Coca-Cola joint venture announced in February (1"The Tan Sheet" March 5, In Brief)

You may also be interested in...



Functional Pringles?

Accelerated introduction of vitamin- and nutrient-fortified snacks and juice beverages may be on the horizon from joint venture recently formed by P&G and Coca-Cola. "Innovation and a substantial new product pipeline" will be P&G's primary forward-looking contributions to the yet-unnamed company, CFO Clayton Daley tells analysts during Merrill Lynch consumer product investor conference Feb. 27. P&G owns approximately 3,000 patents in the food/beverage area, including "substantial positions in calcium, iron, vitamin A and iodine fortification," as well as accompanying flavor-masking technology, Daley notes

Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC

In Brief

Combe sells most of its OTC brands

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS093093

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel